NCT07739914 clinical trial report covering Everolimus, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07738172 clinical trial report covering Osimertinib mesylate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07740421 clinical trial report covering NH-002(Trust Bio-sonics), Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07738276 clinical trial report covering Tirzepatide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07740564 clinical trial report covering OT-202, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07739758 clinical trial report covering Serplulimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07741240 clinical trial report covering KH-607, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07743164 clinical trial report covering Raludotatug deruxtecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07742215 clinical trial report covering BCD-248, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07741331 clinical trial report covering KH-607, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07742735 clinical trial report covering Apraglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07743463 clinical trial report covering ASC-30, Phase 3, endpoints, sponsor, geography, readout timing and development white space.